An interventional study of OTTAVA Robotic System in Obesity, sponsored by Auris Health, Inc.. Completed at 6 sites in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.
Sponsored by Auris Health, Inc. · Not applicable, Interventional, and Treatment
This study assesses safety and performance of the OTTAVA Robotic System, through 30 days postoperative, in subjects undergoing robotic-assisted Roux-en-Y Gastric Bypass (RYGB) procedure.
Criteria for Inclusion:
Criteria for Exclusion:
Procedure with the OTTAVA Robotic System
Device: OTTAVA Robotic System
Procedure with the OTTAVA Robotic System
Procedure completion without conversion to open surgery
Time frame: Procedure day
Occurrence of intraoperative and postoperative device- or procedure-related complications
Time frame: Through 30 days post-procedure
Occurrence of all adverse events
Time frame: Through 30 days post-procedure
Total operative time
Time frame: Procedure day
Estimated blood loss
Time frame: Procedure day
Occurrence of blood transfusion
Time frame: Procedure day
Device malfunction details
Time frame: Procedure day
Length of hospital stay
Time frame: Hospital stay, assessed up to 30 days
Hospital readmission
Time frame: Through 30 days
Reoperation
Time frame: Through 30 days
Anastomotic leak
Time frame: Through 30 days
Anastomotic stricture
Time frame: Through 30 days
Mortality
Time frame: Through 30 days
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Auris Health, Inc.